Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mann

Showing results (1011-1020 of 1,096) with videos related to

Pageof 110
Sort By:
Journal of the American College of Cardiology|January 6, 2026
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Experimental and Clinical Psychopharmacology|July 22, 2021
Influence of personality on acute smoked cannabis effects on simulated drivingChristine M Wickens, Robert E Mann, Bruna Brands, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 13, 2022
Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trialChristine M Wickens, Madison Wright, Robert E Mann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2025
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialMuthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes Care|September 19, 2025
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2025
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristicsRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Mayo Clinic Proceedings|October 5, 2020
Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks-A Narrative ReviewCatherine M Clase, Edouard L Fu, Aurneen Ashur, et al.
The New England Journal of Medicine|June 5, 2025
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 DiabetesRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Pageof 110

Showing results (1011-1020 of 1,096) with videos related to

Sort By:
Pageof 110
Journal of the American College of Cardiology|January 6, 2026
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Experimental and Clinical Psychopharmacology|July 22, 2021
Influence of personality on acute smoked cannabis effects on simulated drivingChristine M Wickens, Robert E Mann, Bruna Brands, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 13, 2022
Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trialChristine M Wickens, Madison Wright, Robert E Mann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2025
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialMuthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes Care|September 19, 2025
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2025
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristicsRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Mayo Clinic Proceedings|October 5, 2020
Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks-A Narrative ReviewCatherine M Clase, Edouard L Fu, Aurneen Ashur, et al.
The New England Journal of Medicine|June 5, 2025
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 DiabetesRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Pageof 110